Chemocentryx Inc. (CCXI)

ChemoCentryx Financial Statements

ChemoCentryx Financial Overview

ChemoCentryx's market cap is currently ―. The company's EPS TTM is $-2; its P/E ratio is -13.35; ChemoCentryx is scheduled to report earnings on August 8, 2022, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 5.46M$ 2.29M$ 17.69M$ 1.70M$ 10.22M
Gross Profit$ 5.25M$ 1.99M$ ―$ ―$ 10.22M
EBIT$ -38.01M$ -39.88M$ -21.64M$ -38.51M$ -29.02M
EBITDA$ -36.99M$ -38.87M$ -20.64M$ -37.51M$ -28.91M
Net Income Common Stockholders$ -38.61M$ -40.53M$ -22.31M$ -39.21M$ -29.71M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 264.49M$ 269.43M$ 312.60M$ 340.60M$ 376.28M
Total Assets$ 440.45M$ 425.65M$ 454.85M$ 467.67M$ 499.11M
Total Debt$ 54.94M$ 58.69M$ 66.75M$ 71.19M$ 73.47M
Net Debt$ -209.56M$ -210.74M$ -245.85M$ -269.41M$ -302.82M
Total Liabilities$ 181.73M$ 139.53M$ 138.95M$ 137.40M$ 138.11M
Stockholders Equity$ 258.72M$ 286.12M$ 315.89M$ 330.27M$ 361.00M
Cash Flow
Free Cash Flow$ 8.61M$ -11.38M$ -29.67M$ -21.15M$ -32.45M
Operating Cash Flow$ 8.83M$ -10.89M$ -25.32M$ -17.85M$ -21.57M
Investing Cash Flow$ -21.34M$ -36.54M$ 42.33M$ 25.77M$ 60.67M
Financing Cash Flow$ 3.10M$ 3.68M$ -489.00K$ 742.00K$ -2.85M
Currency in USD

ChemoCentryx Earnings and Revenue History

ChemoCentryx Debt to Assets

ChemoCentryx Cash Flow

ChemoCentryx Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis